Preferred Label : Prostate Cancer Pathway;

NCIt related terms : Prostate cancer;

Alternative definition : KEGG: The identification of key molecular alterations in prostate-cancer cells implicates carcinogen defenses (GSTP1), growth-factor-signaling pathways (NKX3.1, PTEN, and p27), and androgens (AR) as critical determinants of the phenotype of prostate-cancer cells. Glutathione S-transferases (GSTP1) are detoxifying enzymes that catalyze conjunction of glutathione with harmful, electrophilic molecules, thereby protecting cells from carcinogenic factors. Cells of prostatic intraepithelial neoplasia, devoid of GSTP1, undergo genomic damage mediated by such carcinogens. NKX3.1, PTEN, and p27 regulate the growth and survival of prostate cells in the normal prostate. Inadequate levels of PTEN and NKX3.1 lead to a reduction in p27 levels and to increased proliferation and decreased apoptosis. After therapeutic reduction in the levels of testosterone and dihydrotestosterone, the emergence of androgen-independent prostate cancer has been associated with mutations in the androgen receptor (AR) that permit receptor activation by other ligands, increased expression of androgen receptors accompanying AR amplification, and ligand-independent androgen-receptor activation.;

KEGG ID : hsa05215;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3483677/fr/biopsies-ciblees-dans-le-diagnostic-du-cancer-de-la-prostate-rapport-d-evaluation
2023
France
health technology assessment
diagnosis
Prostate Cancer Pathway
Assay Target Antigen
Prostate Carcinoma
Biopsy of Prostate
prostatic neoplasms
malignant neoplasm prostate
prostate cancer
evaluation studies as topic
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
prostate biopsy
biopsy
biopsy of prostate, nos
no diagnosis
Cancer Diagnosis
neoplasm, malignant
Prostate Cancer pT2c TNM Finding v6 and v7

---
https://pgtmsite.files.wordpress.com/2024/01/docetaxel_prostate_pgtm_20050407.pdf
2005
Canada
drug information
Docetaxel
prostatism, nos
Prostate Cancer Pathway
NCI CTEP SDC Prostate Cancer Sub-Category Terminology
Prostate Carcinoma
prostate cancer
docetaxel
docetaxel
neoplasm, malignant
Prostate Cancer pT2c TNM Finding v6 and v7
prostatic neoplasms
prostate, nos
Docetaxel
malignant neoplasm prostate
Refractory Carcinoma

---
Nous contacter.
14/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.